Inherited basis of visceral, abdominal subcutaneous and gluteofemoral fat depots

Saaket Agrawal, Minxian Wang, Marcus D. R. Klarqvist, Kirk Smith, Joseph H. Shin, Hesam Dashti, Nathaniel Diamant, Seung Hoan Choi, Sean J. Jurgens, Patrick T. Ellinor, Anthony Philippakis, Melina Claussnitzer, Kenney Ng, Miriam S. Udler, Puneet Batra, Amit V. Khera

TL;DR

By leveraging MRI data from nearly 40,000 individuals, researchers have mapped the genetic "blueprint" of where the human body stores fat. The study identifies 178 genetic loci that influence specific fat depots—visceral, subcutaneous, and gluteofemoral—independently of overall BMI, revealing that fat distribution is a highly heritable trait with profound implications for cardiometabolic health.

What Problem Does This Paper Address?

While Body Mass Index (BMI) is the standard clinical measure for obesity, it is a blunt instrument. Two individuals with the identical BMI can have vastly different health profiles based on where their fat is stored. Increased visceral adipose tissue (VAT)—fat around the internal organs—is a major risk factor for type 2 diabetes and heart disease. Conversely, gluteofemoral adipose tissue (GFAT)—fat in the hips and thighs—appears to be metabolically protective.

Previous genetic studies relied on anthropometric proxies like waist-to-hip ratio (WHR). However, these proxies cannot distinguish whether a high ratio is caused by too much belly fat or too little hip fat. This paper aims to disentangle the specific genetic architecture of individual fat depots using high-resolution imaging to move beyond BMI and understand the biological drivers of "metabolically unhealthy" fat distribution.

Methods

The authors employed a multi-pronged genomic approach:

  • Automated Imaging Quantification: They used a deep learning model to precisely quantify VAT, abdominal subcutaneous fat (ASAT), and GFAT volumes from MRI scans.
  • Local Adiposity Phenotypes: To isolate the genetics of distribution from overall size, they created "adjusted" traits (e.g., VATadjBMI) and ratios (e.g., VAT/GFAT).
  • Common Variant Association (CVAS): They performed genome-wide association studies across 27 contexts (9 traits across sex-combined and sex-stratified groups).
  • Rare Variant Analysis: Using exome sequencing data, they looked for rare, high-impact mutations (like those in the PDE3B gene) that influence fat distribution.
  • Polygenic Scoring: They developed scores based on over 1 million genetic variants to predict individuals at the "tails" of fat distribution and correlate those scores with clinical disease outcomes.

Datasets

  • UK Biobank: The primary discovery cohort included up to 38,965 participants with both MRI imaging and genotyping data.
  • Exome Sequencing: A subset of 19,255 individuals was used for the rare-variant association studies.
  • Validation Cohort: Polygenic scores were further validated in an independent dataset of 447,486 genotyped (but not imaged) individuals from the UK Biobank to confirm associations with biomarkers and disease.

Key Insights and Ideas

  • The Brain vs. The Adipocyte: A major "aha" moment was the tissue-enrichment analysis. Global adiposity (BMI) is largely driven by the Central Nervous System (genes affecting appetite and satiety). In contrast, local fat distribution is regulated at the level of the adipocyte (fat cell) and peripheral tissues.
  • Female-Specific Architecture: Fat distribution is significantly more heritable in females than in males. The study identified 25 loci that were genome-wide significant only in women, particularly for gluteofemoral fat.
  • The Protective Power of Hips: The study provides genetic evidence for the "portal hypothesis"—that the inability to store fat safely in gluteofemoral depots (GFAT) forces it into dangerous visceral areas, leading to metabolic "insult."
  • Polygenic Lipodystrophy: While rare mutations cause severe lipodystrophy (inability to store fat correctly), this study suggests a "polygenic" version exists in the general population, where the cumulative effect of many common variants leads to similar, though subtler, metabolic risks.

Key Results

  • 178 unique loci were associated with at least one adiposity trait, including 29 newly identified loci.
  • Heritability: GFAT adjusted for BMI showed a remarkably high heritability of 0.53 in females, compared to 0.31 for BMI itself.
  • Predictive Power: Individuals in the top 5% of the polygenic score for GFATadjBMI were 3.8-fold more likely to actually have extreme gluteofemoral fat volumes.
  • Clinical Outcomes: High polygenic scores for "protective" fat (GFAT) were associated with lower risk of type 2 diabetes (OR 0.60) and hypertension, while high scores for visceral fat (VAT) predicted increased risk for those same conditions.

Limitations and Future Work

  • Ancestry Bias: The study cohort was 97% white, meaning these genetic findings may not generalize perfectly to other ancestral groups.
  • Causality: While the study identifies associations, further functional genomics (e.g., CRISPR screens in adipocyte cell lines) are needed to prove exactly how these genes alter fat storage.
  • Clinical Application: While polygenic scores show strong trends, their use in individual clinical risk prediction (e.g., "precision weight management") requires further validation and cost-benefit analysis.

Summary updated

Abstract

For any given level of overall adiposity, individuals vary considerably in fat distribution. The inherited basis of fat distribution in the general population is not fully understood. Here, we study up to 38,965 UK Biobank participants with MRI-derived visceral (VAT), abdominal subcutaneous (ASAT), and gluteofemoral (GFAT) adipose tissue volumes. Because these fat depot volumes are highly correlated with BMI, we additionally study six local adiposity traits: VAT adjusted for BMI and height (VATadj), ASATadj, GFATadj, VAT/ASAT, VAT/GFAT, and ASAT/GFAT. We identify 250 independent common variants (39 newly-identified) associated with at least one trait, with many associations more pronounced in female participants. Rare variant association studies extend prior evidence for PDE3B as an important modulator of fat distribution. Local adiposity traits (1) highlight depot-specific genetic architecture and (2) enable construction of depot-specific polygenic scores that have divergent associations with type 2 diabetes and coronary artery disease. These results - using MRI-derived, BMI-independent measures of local adiposity - confirm fat distribution as a highly heritable trait with important implications for cardiometabolic health outcomes.
BibTeX
@inproceedings{agrawal2022inherited,
  author = {Saaket Agrawal and Minxian Wang and Marcus D. R. Klarqvist and Kirk Smith and Joseph H. Shin and Hesam Dashti and Nathaniel Diamant and Seung Hoan Choi and Sean J. Jurgens and Patrick T. Ellinor and Anthony Philippakis and Melina Claussnitzer and Kenney Ng and Miriam S. Udler and Puneet Batra and Amit V. Khera},
  title = {{Inherited basis of visceral, abdominal subcutaneous and gluteofemoral fat depots}},
  booktitle = {Nature Communications},
  year = {2022},
  doi = {10.1038/s41467-022-30931-2},
}

Loading related content...

Figure